{
  "cancer_id": "TNBC",
  "drug": "atezolizumab_paclitaxel",
  "source": "GSE169246",
  "reference": "Zhang et al. Cancer Cell 2021",
  "pmid": "34653365",
  "treatment_steps": 10,
  "cell_effects": {
    "Tumor": {
      "proportion_change_rate": 0.00018,
      "direction": "increase",
      "fold_change": 1.1651
    },
    "CD8_T": {
      "proportion_change_rate": -0.00069,
      "direction": "decrease",
      "fold_change": 0.9677
    },
    "Treg": {
      "proportion_change_rate": -0.00082,
      "direction": "decrease",
      "fold_change": 0.87
    },
    "Macrophage": {
      "proportion_change_rate": -0.00107,
      "direction": "decrease",
      "fold_change": 0.9269
    },
    "NK": {
      "proportion_change_rate": 0.00933,
      "direction": "increase",
      "fold_change": 1.2805
    },
    "B_cell": {
      "proportion_change_rate": -0.00694,
      "direction": "decrease",
      "fold_change": 0.7024
    }
  }
}